Schweiger, V.; Bellamoli, P.; Taus, F.; Gottin, L.; Martini, A.; Nizzero, M.; Bonora, E.; Del Balzo, G.; Donadello, K.; Secchettin, E.;
et al. Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients. J. Clin. Med. 2024, 13, 1130.
https://doi.org/10.3390/jcm13041130
AMA Style
Schweiger V, Bellamoli P, Taus F, Gottin L, Martini A, Nizzero M, Bonora E, Del Balzo G, Donadello K, Secchettin E,
et al. Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients. Journal of Clinical Medicine. 2024; 13(4):1130.
https://doi.org/10.3390/jcm13041130
Chicago/Turabian Style
Schweiger, Vittorio, Paola Bellamoli, Francesco Taus, Leonardo Gottin, Alvise Martini, Marta Nizzero, Eleonora Bonora, Giovanna Del Balzo, Katia Donadello, Erica Secchettin,
and et al. 2024. "Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients" Journal of Clinical Medicine 13, no. 4: 1130.
https://doi.org/10.3390/jcm13041130
APA Style
Schweiger, V., Bellamoli, P., Taus, F., Gottin, L., Martini, A., Nizzero, M., Bonora, E., Del Balzo, G., Donadello, K., Secchettin, E., Finco, G., Santis, D. D., & Polati, E.
(2024). Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients. Journal of Clinical Medicine, 13(4), 1130.
https://doi.org/10.3390/jcm13041130